Literature DB >> 18801902

Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor.

Karen Tan1, Irina D Pogozheva, Giles S H Yeo, Dirk Hadaschik, Julia M Keogh, Carrie Haskell-Leuvano, Stephen O'Rahilly, Henry I Mosberg, I Sadaf Farooqi.   

Abstract

Mutations in the melanocortin 4 receptor (MC4R) gene are the most common known cause of monogenic human obesity. The MC4R gene was sequenced in 2000 subjects with severe early-onset obesity. We detected seven different nonsense and 19 nonsynonymous mutations in a total of 94 probands, some of which have been reported previously by others. We functionally characterized the 11 novel obesity associated missense mutations. Seven of these mutants (L54P, E61K, I69T, S136P, M161T, T162I, and I269N) showed impaired cell surface trafficking, reduced level of maximal binding of the radioligand [125I]NDP-MSH, and reduced ability to generate cAMP in response to ligand. Four mutant MC4Rs (G55V, G55D, S136F, and A303T) displayed cell surface expression and agonist binding similar to the wild-type receptor but showed impaired cAMP production, suggesting that these residues are likely to be critical for conformational rearrangement essential for receptor activation. Homology modeling of these mutants using a model of MC4R based on the crystal structure of the beta2-adrenoreceptor was used to provide insights into the possible structural basis for receptor dysfunction. Transmembrane (TM) domains 1, 3, 6, 7, and peripheral helix 8 appear to participate in the agonist-induced conformational rearrangement necessary for coupling of ligand binding to signaling. We conclude that G55V, G55D, S136F, and A303T mutations are likely to strengthen helix-helix interactions between TM1 and TM2, TM3 and TM6, and TM7 and helix 8, respectively, preventing relative movement of these helices during receptor activation. The combination of functional studies and structural modeling of naturally occurring pathogenic mutations in MC4R can provide valuable information regarding the molecular mechanism of MC4R activation and its dysfunction in human disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801902      PMCID: PMC2732289          DOI: 10.1210/en.2008-0721

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  46 in total

1.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

Review 2.  Structural diversity of G protein-coupled receptors and significance for drug discovery.

Authors:  Malin C Lagerström; Helgi B Schiöth
Journal:  Nat Rev Drug Discov       Date:  2008-04       Impact factor: 84.694

3.  Targeting of G protein-coupled receptors to the basolateral surface of polarized renal epithelial cells involves multiple, non-contiguous structural signals.

Authors:  C Saunders; J R Keefer; C A Bonner; L E Limbird
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

4.  Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.

Authors:  H Sadeghi; G L Robertson; D G Bichet; G Innamorati; M Birnbaumer
Journal:  Mol Endocrinol       Date:  1997-11

5.  Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.

Authors:  Zhimin Xiang; Irina D Pogozheva; Nicholas B Sorenson; Andrzej M Wilczynski; Jerry Ryan Holder; Sally A Litherland; William J Millard; Henry I Mosberg; Carrie Haskell-Luevano
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

6.  GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.

Authors:  Daniel M Rosenbaum; Vadim Cherezov; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Xiao-Jie Yao; William I Weis; Raymond C Stevens; Brian K Kobilka
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

7.  Adrenocorticotropin receptor gene mutations in familial glucocorticoid deficiency: relationships with clinical features in four families.

Authors:  A Weber; J Toppari; R D Harvey; R C Klann; N J Shaw; A T Ricker; K Näntö-Salonen; J S Bevan; A J Clark
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

8.  Body mass index reference curves for the UK, 1990.

Authors:  T J Cole; J V Freeman; M A Preece
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

9.  The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line.

Authors:  Sadani N Cooray; Isabel Almiro Do Vale; Kit-Yi Leung; Tom R Webb; J Paul Chapple; Michaela Egertová; Michael E Cheetham; Maurice R Elphick; Adrian J L Clark
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

10.  Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees.

Authors:  Fanny Stutzmann; Karen Tan; Vincent Vatin; Christian Dina; Béatrice Jouret; Jean Tichet; Beverley Balkau; Natascha Potoczna; Fritz Horber; Stephen O'Rahilly; I Sadaf Farooqi; Philippe Froguel; David Meyre
Journal:  Diabetes       Date:  2008-06-16       Impact factor: 9.461

View more
  22 in total

Review 1.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

2.  Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.

Authors:  Zoe M Koerperich; Mark D Ericson; Katie T Freeman; Robert C Speth; Irina D Pogozheva; Henry I Mosberg; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2020-01-06       Impact factor: 7.446

3.  Identification of mutations underlying 20 inborn errors of metabolism in the United Arab Emirates population.

Authors:  Imen Ben-Rebeh; Jozef L Hertecant; Fatma A Al-Jasmi; Hanan E Aburawi; Said A Al-Yahyaee; Lihadh Al-Gazali; Bassam R Ali
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-22

4.  Melanocortin-4 receptor (MC4R) polymorphisms are associated with growth and meat quality traits in sheep.

Authors:  Beiyao Zuo; Guiqiong Liu; Yuqin Peng; Hongguang Qian; Jiasen Liu; Xunping Jiang; Adama Mara
Journal:  Mol Biol Rep       Date:  2014-07-22       Impact factor: 2.316

5.  The cytosolic chaperone Hsc70 promotes traffic to the cell surface of intracellular retained melanocortin-4 receptor mutants.

Authors:  Eirini Meimaridou; Sakina B Gooljar; Nalini Ramnarace; Lucia Anthonypillai; Adrian J L Clark; J Paul Chapple
Journal:  Mol Endocrinol       Date:  2011-06-30

6.  Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.

Authors:  Zhimin Xiang; Bettina Proneth; Marvin L Dirain; Sally A Litherland; Carrie Haskell-Luevano
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

7.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

Review 8.  Neural melanocortin receptors in obesity and related metabolic disorders.

Authors:  Clemence Girardet; Andrew A Butler
Journal:  Biochim Biophys Acta       Date:  2013-05-13

9.  Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.

Authors:  Bethany A Falls; Yan Zhang
Journal:  ACS Chem Neurosci       Date:  2018-08-13       Impact factor: 4.418

10.  Melanocortin-4 receptor signaling is not required for short-term weight loss after sleeve gastrectomy in pediatric patients.

Authors:  E B Jelin; H Daggag; A L Speer; N Hameed; N Lessan; M Barakat; E P Nadler
Journal:  Int J Obes (Lond)       Date:  2015-11-05       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.